Point-of-Care Testing of Triglycerides: Evaluation of the Accutrend Triglycerides System
Claus Luley(Otto-von-Guericke-Universität Magdeburg), Andrew Hattemer(Roche Pharma AG (Germany)), Valerie Paal(St. Bonifatius Hospital), W Reuter(Leipzig University), Stephan J. L. Bakker(University Medical Center Groningen), Hans-Detlev Gottschling, Gunnar Ronquist(Uppsala University Hospital), Sabine Westphal(Nebraska Medical Center), Robert J. Heine(Eli Lilly (United States)), George L. King(Joslin Diabetes Center)
Cited by 58
Related Papers
Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal Disorders
|New England Journal of Medicine|1994|3.8k
SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe
|European Heart Journal|2021|1.7k
Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.
|Proceedings of the National Academy of Sciences|1995|1.3k
Retinopathy in Diabetes
|Diabetes Care|2004|1.1k